Bruckmann, Rosser, Sherrill & Co. Completes Sale of Seroyal to Atrium Innovations Inc.
NEW YORK, January 4, 2011 - Bruckmann, Rosser, Sherrill & Co. (BRS), a New York-based private equity firm, announced today that it successfully sold the assets of Seroyal Holdings L.P. (“Seroyal” or the “Company”) to Atrium Innovations Inc. (“Atrium”). Seroyal, headquartered in Richmond Hill, Ontario, sells branded nutritional supplements and homeopathic remedies to health care practitioners in Canada and the U.S. The Company sells nutritional supplements under its proprietary Genestra and Pharmax brands and homeopathic...
Bruckmann, Rosser, Sherrill & Co. Announces Organizational Changes
NEW YORK, January 3, 2011 -- Bruckmann, Rosser, Sherrill & Co. (BRS), a New York-based private equity firm, today announced that one of its founding partners, Harold (Hal) Rosser, has decided to leave the firm. Mr. Rosser plans to start his own investment firm with two other BRS employees, Jacob Organek and Luke Rosser. Mr. Rosser, Stephen Sherrill and Bruce Bruckmann formed BRS in 1995 after working together for many years at Citicorp Venture Capital....